CURR: CURRENC Group Inc. Stock

by  •  • Comments Off on CURR: CURRENC Group Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 103.29
Enterprise Value ($M) 119.76
Book Value ($M) -22.73
Book Value / Share -0.49
Price / Book -4.54
NCAV ($M) -55.17
NCAV / Share -1.19
Price / NCAV -1.87

Profitability (mra)
Return on Invested Capital (ROIC) -0.87
Return on Assets (ROA) -0.11
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.60
Current Ratio 0.60

Balance Sheet (mrq) ($M)
Current Assets 82.53
Assets 114.96
Liabilities 137.70
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Polar Asset Management Partners Inc. 0.00 -100.00
11-14 13G/A Glazer Capital, Llc 0.00 -100.00
11-13 13G/A Cowen And Company, Llc 0.00 -100.00
09-10 13G/A Vivaldi Asset Management, LLC 0.00 -100.00
09-05 13G/A Wolverine Asset Management Llc 0.00 -100.00
02-13 13G Mizuho Financial Group Inc 7.40
02-12 13G/A Taconic Capital Advisors LP 0.00 -100.00
02-09 13G/A Periscope Capital Inc. 3.70 -75.84

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-10-09 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-10-09 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-10-09 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-21 58,878 397,499 14.81
2025-01-17 62,716 290,946 21.56
2025-01-16 191,570 625,493 30.63

(click for more detail)

Similar Companies
CRON – Cronos Group Inc. CRSP – CRISPR Therapeutics AG
CRVS – Corvus Pharmaceuticals, Inc. CVAC – CureVac N.V.
EOLS – Evolus, Inc.


Financial data and stock pages provided by
Fintel.io